# Direxion Daily S&P Biotech Bear 3X ETF (LABD) — Overview

LABD · NYSE · Fund

Canonical page: https://www.lighthorse.io/tickers/labd

## Price

Last close $8.05 on Oct 15, 2026. 52-week range $5.90 – $32.65.

## Fund profile

LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.

| Metric | Value |
| --- | --- |
| Issuer | Rafferty Asset Management, LLC |
| Industry | Healthcare |
| Inception | May 28, 2015 |
| Assets under management | $134.5M |
| Expense ratio | 1.07% |
| Net asset value | $8.60 (as of Oct 14, 2026) |
| Distributions | Quarterly |
| Leverage | 3x |

## Frequently Asked Questions

### What is Direxion Daily S&P Biotech Bear 3X ETF (LABD)?

LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.

### What is LABD's expense ratio?

Direxion Daily S&P Biotech Bear 3X ETF charges an annual expense ratio of 1.07%. The fund is issued by Rafferty Asset Management, LLC.

### How large is LABD?

Direxion Daily S&P Biotech Bear 3X ETF manages $134.5M in assets and has traded since May 28, 2015.

### How do I buy shares of Direxion Daily S&P Biotech Bear 3X ETF (LABD)?

LABD trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).